Having trouble accessing articles? Reset your cache.

Merck, Simcere JV fallout

A high-profile China joint venture formed in 2011 between Simcere Pharmaceutical Group (Nanjing, China) and Merck & Co. Inc. (NYSE:MRK) appears to be coming to an end, with Simcere taking

Read the full 309 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE